Gill Vikram Jeet Singh, Soni Suha, Shringarpure Manasi, Bhardwaj Sushant, Yadav Narendra Kumar, Patel Ankit, Patel Avaniben
Internal Medicine, Baylor College of Medicine, Houston, USA.
Medicine, Punjab Institute of Medical Sciences, Jalandhar, IND.
Cureus. 2022 Sep 19;14(9):e29317. doi: 10.7759/cureus.29317. eCollection 2022 Sep.
The gut microbiota (GM) has been recognized as an important factor in the development of metabolic diseases such as obesity; it has been reported that the composition of the GM differs in obese and lean subjects, suggesting that microbiota dysbiosis can contribute to changes in body weight. Dysbiosis occurs due to an imbalance in the composition of gut bacteria, changes in the metabolic process, or changes in the distribution of microbiota within the gut. Dysbiosis can change the functioning of the intestinal barrier and the gut-associated lymphoid tissues (GALT). Microbial manipulation may help with preventing or treating weight gain and associated comorbidities. Approaches to this may range from dietary manipulation, which is suitable to treat the individual's microflora, to probiotics, prebiotics, synbiotics, and fecal microbiota transplant (FMT).
肠道微生物群(GM)已被公认为是肥胖等代谢性疾病发展的一个重要因素;据报道,肥胖和消瘦个体的肠道微生物群组成不同,这表明微生物群失调可能导致体重变化。微生物群失调是由于肠道细菌组成失衡、代谢过程变化或肠道内微生物群分布变化引起的。微生物群失调会改变肠道屏障和肠道相关淋巴组织(GALT)的功能。微生物调节可能有助于预防或治疗体重增加及相关合并症。实现这一目标的方法包括从适合治疗个体微生物群的饮食调节到益生菌、益生元、合生元和粪便微生物群移植(FMT)。